← All stocks

Karyopharm Therapeutics Inc.

KPTI Net selling
CIK 0001503802 #4777 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$351.59K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$351.59K
20 of 20 sales
Net
−$351.59K
−$351.59K against sales at will

By person

13 insiders · 20 transactions
0.7×

Richard Paulson holds only 0.7 times base salary in stock. $544.89K of shares against $770.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Paulson last reported holding, valued at $2.02, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Paulson Richard A.
President and CEO
$137.24K (2)
−$137.24K
269,747
$544.89K
+187.8%
Poulton Stuart
EVP, Chief Development Officer
$56.43K (4)
−$56.43K
94,632
$191.16K
+246.7%
Rangwala Reshma
EVP & Chief Medical Officer
$55.56K (3)
−$55.56K
56,829
$114.79K
+148.6%
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
$46.40K (2)
−$46.40K
107,940
$218.04K
+276.3%
Mano Michael
EVP, CLO&Secretary
$35.70K (2)
−$35.70K
94,398
$190.68K
+417.1%
Macomber Lori
EVP, CFO & Treasurer
$10.24K (1)
−$10.24K
85,105
$171.91K
Abate Kristin
Chief Accounting Officer
$10.01K (6)
−$10.01K
23,782
$48.04K
+99.1%
BOHLIN GAREN G
Director
18,517
$37.40K
+515.4%
Greene Barry E
Director
16,415
$33.16K
+1,710%
Oliger Christy J.
Director
15,508
$31.33K
PAKIANATHAN DEEPIKA
Director
15,508
$31.33K
Su Zhen
Director
15,508
$31.33K
Schor Chen
Director
15,508
$31.33K

No percentages here. This company's share count has moved by a factor of 1,973.5 over the window, from 8,639,904 to 17,050,876,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Abate Kristin
1 Sep 2026
Chief Accounting Officer
Sell
19
$2.02
$38.38
Poulton Stuart
28 Jul 2026
EVP, Chief Development Officer
Sell
189
$7.10
$1.34K
Mano Michael
14 May 2026
EVP, CLO&Secretary
Sell
266
$9.50
$2.53K
Paulson Richard A.
14 May 2026
President and CEO
Sell
2,203
$9.50
$20.93K
Abate Kristin
14 May 2026
Chief Accounting Officer
Sell
53
$9.50
$503.50
Cheng Sohanya Roshan
14 May 2026
EVP & Chief Commercial Officer
Sell
324
$9.50
$3.08K
Rangwala Reshma
14 May 2026
EVP & Chief Medical Officer
Sell
408
$9.50
$3.88K
Poulton Stuart
14 May 2026
EVP, Chief Development Officer
Sell
403
$9.50
$3.83K
Rangwala Reshma
21 Apr 2026
EVP & Chief Medical Officer
Sell
449
$8.94
$4.01K
Poulton Stuart
2 Mar 2026
EVP, Chief Development Officer
Sell
5,101
$9.41
$48.00K
Paulson Richard A.
2 Mar 2026
President and CEO
Sell
12,361
$9.41
$116.31K
Rangwala Reshma
2 Mar 2026
EVP & Chief Medical Officer
Sell
5,066
$9.41
$47.67K
Cheng Sohanya Roshan
2 Mar 2026
EVP & Chief Commercial Officer
Sell
4,604
$9.41
$43.32K
Mano Michael
2 Mar 2026
EVP, CLO&Secretary
Sell
3,526
$9.41
$33.18K
Abate Kristin
2 Mar 2026
Chief Accounting Officer
Sell
559
$9.41
$5.26K
Poulton Stuart
17 Feb 2026
EVP, Chief Development Officer
Sell
378
$8.63
$3.26K
Macomber Lori
3 Feb 2026
EVP, CFO & Treasurer
Sell
1,626
$6.30
$10.24K
Abate Kristin
28 Jan 2026
Chief Accounting Officer
Sell
50
$7.03
$351.50
Abate Kristin
21 Jan 2026
Chief Accounting Officer
Sell
265
$5.96
$1.58K
Abate Kristin
1 Oct 2025
Chief Accounting Officer
Sell
362
$6.30
$2.28K

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 642,522
History held since 8 Nov 2016